Legal Representation
Attorney
Rosemary S. Tarlton
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 17, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Apr 15, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 25, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 25, 2003 | EXT1 | S | SOU EXTENSION 1 FILED |
| Sep 10, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 18, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 29, 2002 | NPUB | O | NOTICE OF PUBLICATION |
| Apr 2, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 14, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 29, 2001 | CNRT | F | NON-FINAL ACTION MAILED |
| Aug 28, 2001 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 27, 2001 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
PHARMACEUTICALS, NAMELY, IMPLANTABLE DRUG DELIVERY SYSTEM COMPRISED PRIMARILY OF SUSTAINED RELEASE DRUGS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CANCER AND OTHER SERIOUS AND LIFE-THREATENING DISEASES
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005